Works matching IS 14642662 AND DT 2018 AND VI 19 AND IP 10


Results: 13
    1
    2
    3
    4
    5
    6

    Switching to coformulated rilpivirine (RPV), emtricitabine (FTC) and tenofovir alafenamide from either RPV, FTC and tenofovir disoproxil fumarate (TDF) or efavirenz, FTC and TDF: 96‐week results from two randomized clinical trials.

    Published in:
    HIV Medicine, 2018, v. 19, n. 10, p. 724, doi. 10.1111/hiv.12664
    By:
    • Hagins, D;
    • Orkin, C;
    • Daar, ES;
    • Mills, A;
    • Brinson, C;
    • DeJesus, E;
    • Post, FA;
    • Morales‐Ramirez, J;
    • Thompson, M;
    • Osiyemi, O;
    • Rashbaum, B;
    • Stellbrink, H‐J;
    • Martorell, C;
    • Liu, H;
    • Liu, Y‐P;
    • Porter, D;
    • Collins, SE;
    • SenGupta, D;
    • Das, M
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13

    Issue Information.

    Published in:
    HIV Medicine, 2018, v. 19, n. 10, p. 1, doi. 10.1111/hiv.12556
    Publication type:
    Article